Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

When it comes to developing life-saving vaccines, an important trait to exhibit is a strong sense of altruism. Krishna Ella, founder chairman of Bharat Biotech International Limited (BBIL), seems to know this. In its journey of over two decades, the Hyderabad based company has rolled out crucial vaccines and bio-therapeutics at affordable prices. 

And so, Bharat Biotech — which has got approval for emergency restricted use for its Covid-19 vaccine, Covaxin, along with Serum Institute of India’s Covishield –draws over 80 per cent of its revenues from just its top two or three vaccines. 

Bharat Biotech's journey with Covaxin is